Intravitreal injections of triamcinolone acetonide for severe vitritis in patients with incomplete Behcet's disease

Research output: Contribution to journalArticlepeer-review

Abstract

To report our experience with intravitreal triamcinolone acetonide (IVTA) injections for the treatment of sight-threatening vitritis. Interventional case series. Three patients with acute severe exacerbations of noninfectious panuveitis and vitritis were treated with IVTA injections alone or as an adjunct to systemic immunosuppressive agents. Rapid clearance of the vitreous inflammation with improvement in visual acuity was observed 1 to 2 weeks after injection. The effect lasted 2 to 6 months, with the shortest duration in the vitrectomized eye of Patient 1. Repeated injections were required in all patients. Intravitreal triamcinolone acetonide may be beneficial in selected cases of vitritis. This treatment modality has a rapid effect and may lower the use of systemic agents.

Original languageEnglish
Pages (from-to)666-667
Number of pages2
JournalAmerican Journal of Ophthalmology
Volume138
Issue number4
DOIs
StatePublished - Oct 2004
Externally publishedYes

Fingerprint

Dive into the research topics of 'Intravitreal injections of triamcinolone acetonide for severe vitritis in patients with incomplete Behcet's disease'. Together they form a unique fingerprint.

Cite this